Central ossifying fibroma
Micrograph of a central ossifying fibroma.
Central Ossifying Fibroma is a rare benign tumor that originates from the mesenchymal tissue of the jawbones. It is characterized by the formation of fibrous tissue and the presence of calcified material, resembling bone. This article provides an overview of the central ossifying fibroma, including its etiology, clinical features, diagnosis, and treatment options.
Etiology[edit]
The exact cause of central ossifying fibroma is still unknown. However, it is believed to arise from the cells of the periodontal ligament or the dental follicle. Some studies suggest that trauma or local irritation may play a role in the development of this tumor. Additionally, hormonal factors and genetic predisposition have also been proposed as potential contributing factors.
Clinical Features[edit]
Central ossifying fibroma commonly affects individuals in their second to fourth decades of life, with a slight female predilection. It most commonly occurs in the mandible, particularly in the premolar and molar regions. However, it can also involve the maxilla. Patients may present with painless swelling, facial asymmetry, or displacement of adjacent teeth. In some cases, the tumor may cause expansion of the jawbone, leading to facial deformity.
Diagnosis[edit]
The diagnosis of central ossifying fibroma is based on clinical, radiographic, and histopathological findings. Radiographically, it appears as a well-defined radiolucent lesion with variable amounts of calcifications. Computed tomography (CT) and magnetic resonance imaging (MRI) can provide additional information about the extent and involvement of adjacent structures. Histopathologically, the tumor is characterized by the presence of fibrous connective tissue with varying degrees of calcifications, resembling bone.
Treatment[edit]
The treatment of central ossifying fibroma involves surgical excision of the tumor. The extent of surgery depends on the size and location of the lesion. In some cases, a conservative approach may be adopted, with regular follow-up to monitor any recurrence. Reconstruction of the affected jawbone may be necessary in cases where significant bone loss has occurred. Long-term follow-up is essential to detect any recurrence or malignant transformation.
References[edit]
See Also[edit]
External Links[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian